Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma;Endocrine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07545837
What this trial is testing

Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

Who this might be right for
Thyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma
Mayo Clinic 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07489300
What this trial is testing

Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Not applicableStudy completedNCT01487057
What this trial is testing

Lipid Metabolic Status in Thyroid Carcinoma

Who this might be right for
Thyroid CarcinomaDyslipidemiasRisk Reduction Behavior+1 more
Prof. Dr. I. Chiricuta Institute of Oncology 52
Early research (Phase 1)UnknownNCT01456065
What this trial is testing

Safety of Active Immunotherapy in Subjects With Ovarian Cancer

Who this might be right for
Ovarian Epithelial Cancer
Life Research Technologies GmbH 15
Not applicableUnknownNCT05576519
What this trial is testing

Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian Carcinoma
Sohag University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06690775
What this trial is testing

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Who this might be right for
Epithelial Ovarian CancerPrimary PeritonealFallopian Tube Cancer+1 more
TORL Biotherapeutics, LLC 230
Early research (Phase 1)Ended earlyNCT02687230
What this trial is testing

Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1

Who this might be right for
Pancreatic CarcinomaTumors That Express CA19-9
BioNTech Research & Development, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT06607692
What this trial is testing

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Who this might be right for
Solid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more
Fundación de investigación HM 25
Not applicableLooking for participantsNCT06706700
What this trial is testing

Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas

Who this might be right for
Intraductal Papillary Mucinous Neoplasm of PancreasPancreatic Cyst
IRCCS San Raffaele 586
Early research (Phase 1)Not Yet RecruitingNCT07650357
What this trial is testing

CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerPancreatic Carcinoma+1 more
Clasp Therapeutics, Inc. 140
Testing effectiveness (Phase 2)Study completedNCT00868192
What this trial is testing

Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma

Who this might be right for
Ovarian CarcinomaPrimary Peritoneal Carcinoma
Washington University School of Medicine 38
Testing effectiveness (Phase 2)Looking for participantsNCT04421820
What this trial is testing

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Who this might be right for
Colorectal CancerPancreatic CancerGastric Cancers+1 more
Bold Therapeutics, Inc. 220
Testing effectiveness (Phase 2)Study completedNCT04705818
What this trial is testing

Combining Epigenetic And Immune Therapy to Beat Cancer.

Who this might be right for
Advanced Solid TumorAdvanced Colorectal CarcinomaAdvanced Soft-tissue Sarcoma+2 more
Institut Bergonié 164
Early research (Phase 1)Looking for participantsNCT07619313
What this trial is testing

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced CholangiocarcinomaLocally Advanced Pancreatic Adenocarcinoma+5 more
Jonsson Comprehensive Cancer Center 46
Not applicableActive Not RecruitingNCT01276574
What this trial is testing

Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Turku University Hospital 150
Testing effectiveness (Phase 2)Looking for participantsNCT07495124
What this trial is testing

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

Who this might be right for
Fallopian Tube CarcinomaOvarian CarcinomaPrimary Peritoneal Carcinoma
University of Washington 26
Testing effectiveness (Phase 2)Study completedNCT00861120
What this trial is testing

Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type

Who this might be right for
Epithelial Ovarian Cancer
Vejle Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT06445062
What this trial is testing

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Who this might be right for
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc. 1,130
Not applicableWithdrawnNCT00084370
What this trial is testing

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierOvarian Cancer
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Next Page